Source: American Journal of Cardiology. Unidade: HU
Subjects: INIBIDORES QUÍMICOS, ARTERIOSCLEROSE, RISCO
ABNT
CESENA, Fernando H Y et al. Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted benefit. American Journal of Cardiology, v. 121, n. ju 2018, p. 1315-1320, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.amjcard.2018.02.011. Acesso em: 01 jul. 2024.APA
Cesena, F. H. Y., Laurinavicius, A. G., Valente, V. A., Conceição, R. D., Nasir, K., Santos, R. D., & Bittencourt, M. S. (2018). Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted benefit. American Journal of Cardiology, 121( ju 2018), 1315-1320. doi:10.1016/j.amjcard.2018.02.011NLM
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Nasir K, Santos RD, Bittencourt MS. Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted benefit [Internet]. American Journal of Cardiology. 2018 ; 121( ju 2018): 1315-1320.[citado 2024 jul. 01 ] Available from: https://doi.org/10.1016/j.amjcard.2018.02.011Vancouver
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Nasir K, Santos RD, Bittencourt MS. Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted benefit [Internet]. American Journal of Cardiology. 2018 ; 121( ju 2018): 1315-1320.[citado 2024 jul. 01 ] Available from: https://doi.org/10.1016/j.amjcard.2018.02.011